The binding of drugs by plasma proteins

MC Meyer, DE Guttman - Journal of Pharmaceutical Sciences, 1968 - Elsevier
G tions between drugs and proteins, which was published in 1949, surveyed and summarized
a rather large literature and, in addition, clearly and lucidly emphasized the potential …

The bioinequivalence of carbamazepine tablets with a history of clinical failures

MC Meyer, AB Straughn, EJ Jarvi, GC Wood… - Pharmaceutical …, 1992 - Springer
The bioavailability of three lots of a generic 200-mg carbamazepine tablet, which had been
withdrawn from the market, was compared to the bioavailability of one lot of the innovator …

Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9* 3 allele

RS Kidd, AB Straughn, MC Meyer… - Pharmacogenetics …, 1999 - journals.lww.com
Genetic polymorphisms in the cytochrome P450 (CYP) family are widely known to contribute
to interindividual differences in the pharmacokinetics of many drugs. Several alleles for the …

The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms

Y Chen, TW McCall, AR Baichwal, MC Meyer - Journal of controlled release, 1999 - Elsevier
The objective of this work is to use an artificial neural network (ANN) and pharmacokinetic
simulations in the design of controlled-release formulations with predictable in vitro and in …

The absorption of sustained‐release methylphenidate formulations compared to an immediate‐release formulation

…, EJ Jarvi, GR Breese, MC Meyer - … & drug disposition, 1989 - Wiley Online Library
A crossover study in 18 subjects evaluated the plasma concentration–time profile of two
different 20 mg sustained‐release (SR) methylphenidate (MPH) tablets administered before …

The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules

MC Meyer, AB Straughn, RM Mhatre, A Hussain… - Pharmaceutical …, 2000 - Springer
Purpose. To determine if changes in the in vitrodissolution of hard and soft gelatin
acetaminophen capsules, which resultfrom gelatin crosslinking, are predictive of changes in the …

Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer

…, A Straughn, SL Marcus, AL Golub, MC Meyer - … of Pharmacology and …, 2002 - ASPET
5-Aminolevulinic acid (ALA) is a precursor of protoporphyrin IX (PpIX) that is being evaluated
for use in photodiagnosis and phototherapy of malignant and nonmalignant disorders. …

The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets

MC Meyer, AB Straughn, RM Mhatre, VP Shah… - Pharmaceutical …, 1998 - Springer
Purpose. To determine if three marketed generic carbamazepine tablets were bioequivalent
to the innovator formulation, as well as to each other. In addition, to examine in vivo-in vitro …

Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs

J Meyer, MC Meyer, AL Golub - Drug metabolism and disposition, 1999 - ASPET
The purpose of these studies was to examine the pharmacokinetics, oral bioavailability, and
systemic side effects of aminolevulinic acid (ALA) in beagle dogs after oral and iv …

United States Food and Drug Administration requirements for approval of generic drug products

MC Meyer - Journal of Clinical Psychiatry, 2001 - psychiatrist.com
As generic products become more available for the treatment of psychiatric disorders, clinicians
must stay abreast of the US Food and Drug Administration (FDA) requirements for the …